Diagnosis is made by exclusion of alcohol abuse and other causes of liver disease (HBV-related hepatitis, HCV-related hepatitis, autoimmune liver diseases, polycystic ovary syndrome, drug-induced liver disease and congenital causes such as hereditary hemochromatosis, Wilsons disease, alpha-1 antitrypsin deficit)

If you already understand what compound tirzepatide is and want to know about safety concerns, skip to "Compounded tirzepatide safety risks you should know." Tirzepatide works as a dual agonist, meaning it targets two hormone receptors: Dual agonist mechanism: Tirzepatide activates both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors to reduce appetite and slow digestion Compounding process: Pharmacies mix tirzepatide powder for compounding into injectable or sometimes oral formulations Key distinction: Compounded versions are not the same as FDA-approved Mounjaro or Zepbound The dual mechanism is what sets tirzepatide apart from single-agonist medications like semaglutide
GLP-1 action may potentially sensitize GIP signaling, which is often compromised in individuals with uncontrolled T2DM
This provides our clinical team with full insight into your metabolic status such as thyroid function, liver enzymes, HbA1c and cholesterol, before we prescribe anything
Injection anxiety is common, including among people who are confident about every other part of their health routine